Works matching IS 01615505 AND DT 2023 AND VI 64 AND IP 9

Results: 28

Human Epidermal Growth Factor Receptor 2–Targeting [ 68Ga]Ga-ABY-025 PET/CT Predicts Early Metabolic Response in Metastatic Breast Cancer.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1364, doi. 10.2967/jnumed.122.265364

By:

Alhuseinalkhudhur, Ali;
Lindman, Henrik;
Liss, Per;
Sundin, Tora;
Frejd, Fredrik Y.;
Hartman, Johan;
Iyer, Victor;
Feldwisch, Joachim;
Lubberink, Mark;
Rönnlund, Caroline;
Tolmachev, Vladimir;
Velikyan, Irina;
Sörensen, Jens

Publication type:

Article

Single-Time-Point Imaging for Dosimetry After [ 177Lu]Lu-DOTATATE: Accuracy of Existing Methods and Novel Data-Driven Models for Reducing Sensitivity to Time-Point Selection.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1463, doi. 10.2967/jnumed.122.265338

By:

Chang Wang;
Peterson, Avery B.;
Ka Kit Wong;
Roseland, Molly E.;
Schipper, Matthew J.;
Dewaraja, Yuni K.

Publication type:

Article

The Future of Nuclear Medicine in the United States.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1352, doi. 10.2967/jnumed.122.265314

By:

Graham, Michael M.

Publication type:

Article

[ 18F]FDG PET/CT in the Initial Staging and Restaging of Soft-Tissue or Bone Sarcoma in Patients with Negative or Equivocal Findings for Metastases or Limited Recurrence on Conventional Work-up: Results of a Prospective Multicenter Registry.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1371, doi. 10.2967/jnumed.122.265278

By:

Metser, Ur;
Kulanthaivelu, Roshini;
Salawu, Abdulazeez;
Razak, Albiruni;
Mak, Victor;
Xuan Li;
Langer, Deanna L.;
MacCrostie, Pamela;
Singunkar, Amit

Publication type:

Article

The Future of Nuclear Medicine.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1329, doi. 10.2967/jnumed.123.266448

By:

Mankoff, David

Publication type:

Article

Toward Integrated Independence.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1361, doi. 10.2967/jnumed.123.266395

By:

Delpassand, Ebrahim S.;
Rohren, Eric M.;
Weber, Wolfgang A.;
Czernin, Johannes

Publication type:

Article

Pretargeted Radioimmunotherapy of Ovarian Cancer with 225Ac and an Internalizing Antibody.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1446, doi. 10.2967/jnumed.123.266026

By:

Xiaoyan Li;
Xiaoli Lan;
Weibo Cai

Publication type:

Article

SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-PSMA-617 Radionuclide Therapy.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1417, doi. 10.2967/jnumed.123.265952

By:

Hope, Thomas A.;
Antonarakis, Emmanuel S.;
Bodei, Lisa;
Calais, Jeremie;
Iravani, Amir;
Jacene, Heather;
Koo, Phillip J.;
Morgans, Alicia K.;
Osborne, Joseph R.;
Tagawa, Scott T.;
Taplin, Mary-Ellen;
Sartor, Oliver;
Morris, Michael J.

Publication type:

Article

The Tyr Phenomenon: A Hypocalcemic Response in High-Volume Treatment Responders to 177Lu-Prostate-Specific Membrane Antigen Therapy.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1412, doi. 10.2967/jnumed.123.265759

By:

Kumar, Shejil;
Crumbaker, Megan;
Harvey, Christopher;
Pathmanandavel, Sarennya;
John, Nikieth;
Swiha, Mina M.;
McDonald, Michelle M.;
Clifton-Bligh, Roderick;
7–, Adrian Lee;
Bastick, Patricia;
Counter, William;
Nguyen, Andrew;
Emmett, Louise

Publication type:

Article

Performance of 68Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT in Evaluation of Erdheim–Chester Disease: A Comparison with 18F-FDG PET/CT.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1385, doi. 10.2967/jnumed.123.265691

By:

Jiangyu Ma;
Qiao Yang;
Li Huo;
Jiawen Dai;
Na Niu;
Xinxin Cao

Publication type:

Article

Stronger Together—Collaboration Will Only Enhance Patient Care.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1356, doi. 10.2967/jnumed.123.265673

By:

Grady, Erin E.;
Mankoff, David A.;
Schuster, David M.

Publication type:

Article

Redesigned Curricula, Stringent Licensing Criteria, and Integrated Independence Are Conditions for a Bright Future for Nuclear Medicine in the United States.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1359, doi. 10.2967/jnumed.123.265672

By:

Czernin, Johannes;
Calais, Jeremie

Publication type:

Article

Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1449, doi. 10.2967/jnumed.123.265599

By:

Yizhen Pang;
Liang Zhao;
Jianyang Fang;
Jianhao Chen;
Lingxin Meng;
Long Sun;
Hua Wu;
Zhide Guo;
Qin Lin;
Haojun Chen

Publication type:

Article

Preclinical Characterization of the Tau PET Tracer [ 18F]SNFT-1: Comparison of Tau PET Tracers.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1495, doi. 10.2967/jnumed.123.265593

By:

Ryuichi Harada;
Pradith Lerdsirisuk;
Yuki Shimizu;
Yuka Yokoyama;
Yiqing Du;
Kaede Kudo;
Michinori Ezura;
Yoichi Ishikawa;
Ren Iwata;
Miho Shidahara;
Aiko Ishiki;
Akio Kikuchi;
Yuya Hatano;
Tomohiko Ishihara;
Osamu Onodera;
Yasushi Iwasaki;
Mari Yoshida;
Yasuyuki Taki;
Hiroyuki Arai;
Yukitsuka Kudo

Publication type:

Article

Pain Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with 223Ra: PARABO, a Prospective, Noninterventional Study.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1392, doi. 10.2967/jnumed.123.265557

By:

Palmedo, Holger;
Ahmadzadehfar, Hojjat;
Eschmann, Susanne;
Niesen, Andreas;
Schönberger, Johann;
Barsegian, Vahe;
Liepe, Knut;
Mottaghy, Felix M.;
Guan, Rongjin;
Pinkert, Joerg;
Sandström, Per;
Herrmann, Ken

Publication type:

Article

Fibroblast Activation Protein and Glycolysis in Lymphoma Diagnosis: Comparison of 68Ga-FAPI PET/CT and 18F-FDG PET/CT.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1399, doi. 10.2967/jnumed.123.265530

By:

Xuetao Chen;
Shuailiang Wang;
Yumei Lai;
Guochang Wang;
Maomao Wei;
Xiao Jin;
Jin Ding;
Yan Zhang;
Yunfei Shi;
Feng Wang;
Hua Zhu;
Zhi Yang;
Xuejuan Wang

Publication type:

Article

Multimodality Imaging of Aortic Valve Calcification and Function in a Murine Model of Calcific Aortic Valve Disease and Bicuspid Aortic Valve.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1487, doi. 10.2967/jnumed.123.265516

By:

Ahmad, Azmi A.;
Ghim, Mean;
Toczek, Jakub;
Neishabouri, Afarin;
Ojha, Devi;
Zhengxing Zhang;
Gona, Kiran;
Raza, Muhammad Zawwad;
Jae-Joon Jung;
Kukreja, Gunjan;
Jiasheng Zhang;
Guerrera, Nicole;
Chi Liu;
Sadeghi, Mehran M.

Publication type:

Article

Monte Carlo Simulations Corroborate PET-Measured Discrepancies in Activity Assessments of Commercial 90Y Vials.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1471, doi. 10.2967/jnumed.123.265494

By:

Auditore, Lucrezia;
Pistone, Daniele;
Italiano, Antonio;
Amato, Ernesto;
Gnesin, Silvano

Publication type:

Article

CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell Tumors.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1424, doi. 10.2967/jnumed.123.265464

By:

Hartlapp, Ingo;
Hartrampf, Philipp E.;
Serfling, Sebastian E.;
Wild, Vanessa;
Weich, Alexander;
Rasche, Leo;
Roth, Sabine;
Rosenwald, Andreas;
Mihatsch, Patrick W.;
Hendricks, Anne;
Wiegering, Armin;
Wiegering, Verena;
Hänscheid, Heribert;
Schirbel, Andreas;
Werner, Rudolf A.;
Buck, Andreas K.;
Wester, Hans-Jürgen;
Einsele, Hermann;
Kunzmann, Volker;
Lapa, Constantin

Publication type:

Article

Specific Uptake in the Bone Marrow Causes High Absorbed Red Marrow Doses During [177Lu]Lu-DOTATATE Treatment.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1456, doi. 10.2967/jnumed.123.265484

By:

Hemmingsson, Jens;
Svensson, Johanna;
Hallqvist, Andreas;
Smits, Katja;
Johanson, Viktor;
Bernhardt, Peter

Publication type:

Article

PSMA-Negative Lesion Progression Under 177Lu-PSMA Radioligand Therapy.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1502, doi. 10.2967/jnumed.122.265099

By:

Murthy, Vishnu;
Allen-Auerbach, Martin;
Lam, Richard;
Owen, Dawn;
Czernin, Johannes;
Calais, Jeremie

Publication type:

Article

Efficacy of HER2-Targeted Intraperitoneal 225Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1439, doi. 10.2967/jnumed.122.265095

By:

Chung, Sebastian K.;
Vargas, Daniela Burnes;
Chandler, Christopher S.;
Katugampola, Sumudu;
Veach, Darren R.;
McDevitt, Michael R.;
Seo, Shin H.;
Vaughn, Brett A.;
Rinne, Sara S.;
Punzalan, Blesida;
Patel, Mitesh;
Hong Xu;
Hong-Fen Guo;
Zanzonico, Pat B.;
Monette, Sébastien;
Guangbin Yang;
Ouerfelli, Ouathek;
Nash, Garrett M.;
Cercek, Andrea;
Fung, Edward K.

Publication type:

Article

Marshalling the Potential of Auger Electron Radiopharmaceutical Therapy.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1344, doi. 10.2967/jnumed.122.265039

By:

Bolcaen, Julie;
Gizawy, Mohamed A.;
Terry, Samantha Y. A.;
Paulo, António;
Cornelissen, Bart;
Korde, Aruna;
Engle, Jonathan;
Radchenko, Valery;
Howell, Roger W.

Publication type:

Article

New Developments in Myeloma Treatment and Response Assessment.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1331, doi. 10.2967/jnumed.122.264972

By:

Kraeber-Bodéré, Françoise;
Jamet, Bastien;
Bezzi, Davide;
Zamagni, Elena;
Moreau, Philippe;
Nanni, Cristina

Publication type:

Article

Head-to-Head Comparison of 68Ga-NODAGA-JR11 and 68Ga-DOTATATE PET/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: Interim Analysis of a Prospective Bicenter Study.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1406, doi. 10.2967/jnumed.122.264890

By:

Zefang Lin;
Wenjia Zhu;
Jiaying Zhang;
Weibing Miao;
Shaobo Yao;
Li Huo

Publication type:

Article

Phase I Study of [68Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I).

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1378, doi. 10.2967/jnumed.122.264853

By:

Gondry, Odrade;
Xavier, Catarina;
Raes, Laurens;
Heemskerk, Johannes;
Devoogdt, Nick;
Everaert, Hendrik;
Breckpot, Karine;
Lecocq, Quentin;
Decoster, Lore;
Fontaine, Christel;
Schallier, Denis;
Aspeslagh, Sandrine;
Vaneycken, Ilse;
Raes, Geert;
Van Ginderachter, Jo A.;
Lahoutte, Tony;
Caveliers, Vicky;
Keyaerts, Marleen

Publication type:

Article

Dual-Time-Point Posttherapy 177Lu-PSMA-617 SPECT/CT Describes the Uptake Kinetics of mCRPC Lesions and Prognosticates Patients’ Outcome.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1431, doi. 10.2967/jnumed.122.264770

By:

Straub, Manuela;
Kupferschläager, Jüurgen;
Serna Higuita, Lina Maria;
Weissinger, Matthias;
Dittmann, Helmut;
la Fougere, Christian;
Fiz, Francesco

Publication type:

Article

Temporal Changes in Coronary 18F-Fluoride Plaque Uptake in Patients with Coronary Atherosclerosis.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1478, doi. 10.2967/jnumed.122.264331

By:

Daghem, Marwa;
Adamson, Philip D.;
Kang-Ling Wang;
Doris, Mhairi;
Rong Bing;
van Beek, Edwin J. R.;
Forsyth, Laura;
Williams, Michelle C.;
Tzolos, Evangelos;
Dey, Damini;
Slomka, Piotr J.;
Dweck, Marc R.;
Newby, David E.;
Moss, Alastair J.

Publication type:

Article

Works matching IS 01615505 AND DT 2023 AND VI 64 AND IP 9

Human Epidermal Growth Factor Receptor 2–Targeting [ <sup>68</sup>Ga]Ga-ABY-025 PET/CT Predicts Early Metabolic Response in Metastatic Breast Cancer.

Single-Time-Point Imaging for Dosimetry After [ <sup>177</sup>Lu]Lu-DOTATATE: Accuracy of Existing Methods and Novel Data-Driven Models for Reducing Sensitivity to Time-Point Selection.

The Future of Nuclear Medicine in the United States.

[ <sup>18</sup>F]FDG PET/CT in the Initial Staging and Restaging of Soft-Tissue or Bone Sarcoma in Patients with Negative or Equivocal Findings for Metastases or Limited Recurrence on Conventional Work-up: Results of a Prospective Multicenter Registry.

The Future of Nuclear Medicine.

Toward Integrated Independence.

Pretargeted Radioimmunotherapy of Ovarian Cancer with <sup>225</sup>Ac and an Internalizing Antibody.

SNMMI Consensus Statement on Patient Selection and Appropriate Use of <sup>177</sup>Lu-PSMA-617 Radionuclide Therapy.

The Tyr Phenomenon: A Hypocalcemic Response in High-Volume Treatment Responders to <sup>177</sup>Lu-Prostate-Specific Membrane Antigen Therapy.

Performance of <sup>68</sup>Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT in Evaluation of Erdheim–Chester Disease: A Comparison with <sup>18</sup>F-FDG PET/CT.

Stronger Together—Collaboration Will Only Enhance Patient Care.

Redesigned Curricula, Stringent Licensing Criteria, and Integrated Independence Are Conditions for a Bright Future for Nuclear Medicine in the United States.

Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy.

Preclinical Characterization of the Tau PET Tracer [ <sup>18</sup>F]SNFT-1: Comparison of Tau PET Tracers.

Pain Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with <sup>223</sup>Ra: PARABO, a Prospective, Noninterventional Study.

Fibroblast Activation Protein and Glycolysis in Lymphoma Diagnosis: Comparison of <sup>68</sup>Ga-FAPI PET/CT and <sup>18</sup>F-FDG PET/CT.

Multimodality Imaging of Aortic Valve Calcification and Function in a Murine Model of Calcific Aortic Valve Disease and Bicuspid Aortic Valve.

Monte Carlo Simulations Corroborate PET-Measured Discrepancies in Activity Assessments of Commercial <sup>90</sup>Y Vials.

CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell Tumors.

Specific Uptake in the Bone Marrow Causes High Absorbed Red Marrow Doses During [<sup>177</sup>Lu]Lu-DOTATATE Treatment.

PSMA-Negative Lesion Progression Under <sup>177</sup>Lu-PSMA Radioligand Therapy.

Efficacy of HER2-Targeted Intraperitoneal <sup>225</sup>Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis.

Marshalling the Potential of Auger Electron Radiopharmaceutical Therapy.

New Developments in Myeloma Treatment and Response Assessment.

Head-to-Head Comparison of <sup>68</sup>Ga-NODAGA-JR11 and <sup>68</sup>Ga-DOTATATE PET/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: Interim Analysis of a Prospective Bicenter Study.

Phase I Study of [<sup>68</sup>Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I).

Dual-Time-Point Posttherapy <sup>177</sup>Lu-PSMA-617 SPECT/CT Describes the Uptake Kinetics of mCRPC Lesions and Prognosticates Patients’ Outcome.

Temporal Changes in Coronary <sup>18</sup>F-Fluoride Plaque Uptake in Patients with Coronary Atherosclerosis.